Breast Cancer Research and Treatment

, Volume 57, Issue 3, pp 291–295 | Cite as

Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors

  • Richard J. BarthJr.


Background: Pathologists can distinguish benign phyllodes tumors, which very rarely metastasize, from malignant phyllodes tumors, which metastasize in approximately one fourth of patients. However, whether these same histologic criteria can be used to predict the likelihood that a phyllodes tumor will locally recur after breast conserving therapy remains controversial.

Study Design: Since few patients with malignant phyllodes tumors have been treated with breast conserving surgery in any individual series, the literature was reviewed using a Medline search.

Results: After local excision, 21 (111/540), 46 (18/39), and 65 (26/40) of patients with benign, borderline, and malignant phyllodes tumors, respectively, recurred in the breast. Following wide local excision, 8 (17/212), 29 (20/68), and 36 (16/45) of patients with benign, borderline, and malignant phyllodes tumors recurred in the breast.

Conclusions: Malignant phyllodes tumors are much more likely than benign phyllodes tumors to recur in the breast after breast conserving surgery. This high rate of local recurrence of borderline and malignant phyllodes tumors suggests that wide local excision is less than optimal therapy, and challenges us to look for methods to improve local tumor control.

phyllodes tumor breast conserving therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pietruszka M, Barnes L: Cystosarcoma phyllodes. Cancer 41: 1974–dy1983, 1978Google Scholar
  2. 2.
    Haagensen C: Cystosarcoma phyllodes. In: Haagensen C (ed) Diseases of the Breast. 3rd edition. WB Saunders, Phil., 1986, pp 284–312Google Scholar
  3. 3.
    Rosai J: Phyllodes tumor. In: Rosai J (ed) Ackerman's Surgical Pathology. 8th edition. Mosby, Boston, 1996, pp 1628–1630Google Scholar
  4. 4.
    Petrek J: Cystosarcoma phyllodes. In: Harris J, Hellman S, Henderson I, Kinne D (eds) Breast Diseases. 3rd edition. JB Lippincott, Phil., 1996, pp 791–797Google Scholar
  5. 5.
    Bernstein L, Deapen D, Ross R: The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 71: 3020-3024, 1993Google Scholar
  6. 6.
    Moffat C, Pinder S, Dixon A, Elston C, Blamey R, Ellis I: Phyllodes tumors of the breast: a clinicopathological review of thirty-two cases. Histopathology 27: 205–218, 1995Google Scholar
  7. 7.
    Kario K, Maeda S, Mizuno Y, Makino Y, Tankawa H, Kitazawa S: Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. J Surg Oncol 45: 46–51, 1990Google Scholar
  8. 8.
    Halverson J, Hori-Rubaina J: Cystosarcoma phyllodes of the breast. Am Surg 40: 295–301, 1974Google Scholar
  9. 9.
    Grimes M: Cystosarcoma phyllodes of the breast. Modern Pathol 5: 232–239, 1992Google Scholar
  10. 10.
    Ward R, Evans H: Cystosarcoma phyllodes. Cancer 58: 2282–2289, 1986Google Scholar
  11. 11.
    Bennett I, Khan A, DeFrietas R, Chaudary M, Millis R: Phyllodes tumors: a clinicopathological review of 30 cases. Aust NZ J Surg 62: 628–633, 1992Google Scholar
  12. 12.
    Rowell M, Perry R, Hsiu J, Barranco S: Phyllodes tumors. Am J Surg 165: 376–379, 1993Google Scholar
  13. 13.
    Azzopardi J: Problems in Breast Pathology. WB Saunders, 1979, pp 346–365Google Scholar
  14. 14.
    Salvadori B, Cusumano F, del Bo R, Delledonne V, Grassi M, Rovini D, Saccozzi R, et al.: Surgical treatment of phyllodes tumors of the breast. Cancer 63: 2532–2536, 1989Google Scholar
  15. 15.
    Ciatto S, Bonardi R, Cataliotti L, Cardona G: Phyllodes tumor of the breast: a multicenter series of 59 cases. Eur J Surg Oncology 18: 545–549, 1992Google Scholar
  16. 16.
    Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K: The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer 77: 910-916, 1996Google Scholar
  17. 17.
    Hajdu S, Espinosa M, Robbins G: Recurrent cystosarcoma phyllodes. Cancer 38: 1402–1406, 1976Google Scholar
  18. 18.
    Treves N, Sunderland D: Cystosarcoma phyllodes of the breast: a malignant and a benign tumor. Cancer 4: 1286–1332, 1951Google Scholar
  19. 19.
    Zurrida 5, Bartoli C, Galimberti V, Squicciarini P, Delledonne V, Veronesi P, Bono A, et al.: Which therapy for unexpected phyllode tumor of the breast? Eur J Cancer 28: 654–657, 1992Google Scholar
  20. 20.
    Lester J, Stout A: Cystosarcoma phyllodes. Cancer 7: 335–353, 1954Google Scholar
  21. 21.
    Oberman H: Cystosarcoma phyllodes. Cancer 18: 697–710, 1965Google Scholar
  22. 22.
    Contarini O, Urdaneta L, Hagen W, Stephenson S: Cystosarcoma phyllodes of the breast. Am Surg 48: 157–165, 1982Google Scholar
  23. 23.
    Hines J, Murad T, Beal J: Prognostic indicators in cystosarcoma phyllodes. Am J Surg 153: 276–280, 1987Google Scholar
  24. 24.
    Hart J, Layfield L, Trumball W, Brayton D, Barker W, Giuliano A: Practical aspects in the diagnosis and management of cystosarcoma phyllodes. Arch Surg 123: 1079–1083, 1988Google Scholar
  25. 25.
    Chua C, Thomas A, Ng B: Cystosarcoma phyllodes: a review of surgical options. Surgery 105: 141–147, 1989Google Scholar
  26. 26.
    Chatson G, Anderson C, Berman M, Deckers P: Phyllodes tumors. Contemp Surg 40: 36–41, 1992Google Scholar
  27. 27.
    Stebbing J, Nash A: Diagnosis and management of phyllodes tumor of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl 77: 181–184, 1995Google Scholar
  28. 28.
    Hopkins M, McGowan T, Rawlings G, Liu F, Fyles A, Yeoh J, Manchul L, et al.: Phyllodes tumor of the breast: a report of 14 cases. J Surg Oncol 56: 108–112, 1994Google Scholar
  29. 29.
    Grigioni W, Santini D, Grassigli A, Taffurelli M, Milani M, Vanzo M, Marrano D: A clinico-pathologic study of cystosarcoma phyllodes. Arch Anat Cytol Path 30: 303–306, 1982Google Scholar
  30. 30.
    Modena S, Prati G, Mainente M, Massocco A, Montresor E, Pelosi G, Iannucci A: Phyllodes tumor of the breast. Eur J Surg Oncol 19: 70–73, 1993Google Scholar
  31. 31.
    Staren E, Lynch G, Boyle C, Witt T, Bines S: Malignant cystosarcoma phyllodes. Am Surg 60: 583–585, 1994Google Scholar
  32. 32.
    Palmer M, DeRisi D, Pelikan A, Patel J, Nemoto T, Rosner D, Dao T: Treatment options and recurrence patterns for cystosarcoma phyllodes. Surg Gyn Obst 170: 193–196, 1990Google Scholar
  33. 33.
    Reinfuss M, Mitus J, Smolak K, Stelmach A: Malignant phyllodes tumors of the breast. Eur J Cancer 29A: 1252–1256, 1993Google Scholar
  34. 34.
    Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, et al.: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. NEJM 320: 822–828, 1989Google Scholar
  35. 35.
    Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, et al.: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. NEJM 328: 1587–1591, 1993Google Scholar
  36. 36.
    Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher E, et al.: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16: 441–452, 1998Google Scholar
  37. 37.
    Marcus S, Merino M, Glatstein E, et al.: Long-term outcome in 87 patients with low-grade soft-tissue sarcoma. Arch Surg 128: 1336–1343, 1993Google Scholar
  38. 38.
    Suit H, Russell W, Martin R: Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer 35: 1478, 1975Google Scholar
  39. 39.
    Pisters P, Harrison L, Leung D, et al.: Long term results of a prospective randomized trial evaluating the role of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14: 859, 1996Google Scholar
  40. 40.
    Hoover H, Testioteanu A, Ketcham A: Metastatic cystosarcoma phyllodes in an adolescent girl. Ann Surg 181: 279–282, 1975Google Scholar
  41. 41.
    Burton G, Hart L, Leight G, Iglehart I, McCarty K, Cox E: Cystosarcoma phyllodes, effective therapy with cisplatin and etoposide chemotherapy. Cancer 63: 2088–2092, 1989Google Scholar
  42. 42.
    Thomas A, Ashworth B, Blake P: Regression of recurrent cystosarcoma phyllodes tumor after neutron treatment. Br J Rad 57: 926–929, 1984Google Scholar
  43. 43.
    Allen R, Nixon D, York M, Coleman J: Successful chemotherapy for cystosarcoma phyllodes. Arch Int Med 145: 1127–1128, 1985Google Scholar
  44. 44.
    Turalba C, El-Mahdi A, Ladga L: Fatal metastatic cystosarcoma phyllodes. J Surg Oncol 33: 176–781, 1986Google Scholar
  45. 45.
    Rissanen P, Holsti P: A retrospective study of sarcoma of the breast. Oncology 22: 258–268, 1968Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Richard J. BarthJr.
    • 1
  1. 1.Dartmouth‐Hitchcock Medical CenterLebanonUSA

Personalised recommendations